Queensland COVID-19 research
This page of Queensland’s research related to the COVID-19 pandemic is compiled from information provided by Queensland universities and research institutes.
While many of our researchers are working on potential vaccines, treatments and other medical interventions, other researchers are applying their expertise to other impacts of the pandemic upon our economy and other aspects of society. The data includes immediate research activity, recent relevant work, proposed research (subject to available funds) and other responses using the resources and expertise of our research organisations.
Listing 5 matching responses out of 149 total responses.
-
A systematic review of soap versus sanitiser for preventing the transmission of acute respiratory infections September 2021
Early on in the COVID-19 pandemic researchers from the Institute for Evidence-Based Healthcare undertook a systematic review of randomised trials to compare the effectiveness of hand hygiene using alcohol-based hand sanitiser to soap and water for preventing the transmission of acute respiratory infections, and assess the relationship between the dose of hand hygiene and the number of acute respiratory infections, influenza-like illness, or influenza events. The review concluded that dequately performed hand hygiene, with either soap or sanitiser, reduces the risk of acute respiratory infections virus transmission, however direct and indirect evidence suggest sanitiser might be more effective in practice.
#Treatment#Prevention#Personal Protective Equipment (PPE)#Infection management
- Centre
-
Institute for Evidence-Based Healthcare
Bond University - Contact details
- Prof Tammy Hoffmann
Epidemiologist
thoffmann@bond.edu.au
+617 5595 5522 - Collaborations
-
- Co-researchers: Dr Mina Bakhit - Institute for Evidence-Based Healthcare
- Dr Natalia Krzyzaniak - Institute for Evidence-Based Healthcare
- Prof Chris del Mar - Institute for Evidence-Based Healthcare
- Asst Prof Anna Scott - Institute for Evidence-Based Healthcare
- Prof Paul Glasziou - Institute for Evidence-Based Healthcare
-
Better statistical methods to discover host genetic factors in symptom response to SARS-CoV-2 infection August 2021
The COVID-19 pandemic has infected >5 million people worldwide. While the majority of infected individuals recover within a few weeks of infection, others develop severe forms, that in some cases prove fatal. To date, the causes of differences in symptom response are unknown. In this proposal, we seek to discover genetic factors that can contribute to explaining these differences. Our findings have the potential to inform the design and analysis of clinical trials for vaccines and treatments.
#Diagnostics#Infection management#Treatment
- Centre
-
Institute for Molecular Bioscience
The University of Queensland - Contact details
- Dr Loic Yengo Dimbou
ARC DECRA Fellow
l.yengo@imb.uq.edu.au
+617 3346 2095 - Collaborations
-
- Collaborators:
- Professor Peter Visscher, Institute for Molecular Bioscience
- Professor Naomi Wray, Institute for Molecular Bioscience
- Jian Yang, , Institute for Molecular Bioscience
- Dr Kirsty Short, School of Chemistry and Molecular Biosciences
- Martin Tobin, UK Biobank
- Harold Sneider, Lifelines Biobank, Netherlands
-
The Immuno-Storm Chip for COVID-19 patients - An early warning for immune system over-reaction in cancer treatment and COVID-19 August 2021
The team at the Centre for Personalised Nanomedicine, led by Prof Matt Trau, have developed a nanopillar chip to read molecular signatures in the blood, such as those left by immune cells. The latest data show that the majority of COVID-19 deaths seem to arise (very quickly) after a cytokine storm where the immune system of a patient over-responds to the infection, killing the patient. Deploying this technology, to detect these cytokine storms early, could save many lives by prioritising hospital treatment and resources to those patients in danger.
#Diagnostics#Infection management#Treatment
- Centre
-
Australian Institute for Bioengineering and Nanotechnology
The University of Queensland - Contact details
- Professor Matt Trau
Senior Group Leader
m.trau@uq.edu.au
+617 3346 4173 - Collaborations
-
- Collaborators:
- Dr Alain Wuethrich, Australian Institute for Bioengineering and Nanotechnology
- Ms Junrong Li, Australian Institute for Bioengineering and Nanotechnology
- Dr Andreas Behren at the Olivia Newton John Cancer Centre
-
Researchers develop direct-acting antiviral therapy to treat COVID-19 May 2021
Scientists from Menzies Health Institute Queensland and City of Hope in the US have developed an experimental direct-acting antiviral for COVID-19. They used gene-silencing RNA technology - siRNA (small-interfering RNA) to attack the virus’s genome directly. This stops the virus from replicating and is delivers the siRNA to the lungs by lipid nanoparticles. This still experimental treatment was designed at Griffith University and City of Hope. The treatment reduces viral load by 99.9% and is designed to work on all betacoronaviruses such as the original SARS virus (SARS-CoV-1) as well as SARS-CoV-2 and any new variants that may arise in the future.
#Immunology#Infection management
- Centre
-
Menzies Health Institute Queensland
Griffith University - Contact details
- Prof Nigel McMillan
Program Director Infectious Diseases and Immunology
n.mcmillan@griffith.edu.au
+61 0413 730 894 - Collaborations
-
- Collaborator: Beckman Research Institute - City of Hope USA
- Funder: Medical Research Futures Fund - Australian Government
-
Antiviral and antibacterial surfaces using nanotechnology for Queensland hospitals August 2020
The emergence of COVID-19, for which there are currently no medications or vaccines, and the rise of antibiotic resistant superbugs, reveals a critical need to develop and implement technologies that prevent pathogen surface transmission. This Advance Queensland Industry Research Fellowship project led by Dr Alka Jaggessar from QUT’s School of Mechanical, Medical and Process Engineering will use nanotechnology to develop surfaces that deactivate viruses and bacteria in Queensland hospitals, reducing the spread of infectious diseases such as COVID-19.
#Infection management
- Centre
-
School of Mechanical, Medical and Process Engineering
Queensland University of Technology - Contact details
- Dr Alka Jaggessar
alka.jaggessar@qut.edu.au - Collaborations
-
- Sri Medical Devices and Healthcare Solutions
- Panda Healthcare Pty Ltd
- Royal Brisbane and Women’s Hospital
Other Queensland COVID-19 initiatives
- Queensland Government
- Coronavirus (COVID-19) business assistance finder
- Life Sciences Queensland
- Life Sciences Queensland joins the data-powered alliance to stop COVID-19
Key Australian COVID-19 initiatives
- Australian Academy of Science
- Rapid Research Information Forum (RRIF)
- COVID-19 Expert Database
Key international COVID-19 initiatives
- CORD-19 (COVID-19 Open Research Dataset)
- Free database of 130,000 plus COVID-19 open research papers